Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Terumo Aortic Global Endovascular Registry

Key facts

Who runs it
Vascutek Ltd.
Where
Lucerne and Lugano, SwitzerlandSee the 2 sitesAlso in 9 other countries, 56 sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
17 Dec 2019
Expected to end
Nov 2030
Type of study
Observational, 4 groups
Treatments tested
  • Thoracic
  • Abdominal
  • Custom Device
  • Illiac Artery
Record updated
13 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Minimum age as per local regulations
  • Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
  • Ability to provide informed consent; o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR)
  • Willingness to comply with the registry protocol
  • Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up

Who cannot take part

  • Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure

Where in Switzerland

Also in 9 other countries, 56 sites

  • Luzerner KantonsspitalLucerne, SwitzerlandContact: Maani HakimiTaking people
  • Civico, Ospedale RegionaleLugano, SwitzerlandContact: Michelle DurnanNo longer taking part

About the trial

What the trial wants to find out

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

The 4 groups in the trial

  • Thoracic - TEVAR

    Treatment: Thoracic

  • Abdominal - EVAR

    Treatment: Abdominal

  • Custom Device
  • Other indications

    Isolated Iliac Artery Aneurysm (IIAA)

    Treatment: Illiac Artery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts
Record updated
13 March 2026